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http://dxObjective: Although hyperlactatemia after cardiac surgery is common, the implications of raised levels remain
controversial. The aim of this study was to evaluate whether high lactate levels after cardiac surgery are predic-
tors of major complications including mortality.
Patients and Methods: This was a substudy of TRACS (Transfusion Requirements After Cardiac Surgery),
which was designed as a prospective, randomized, controlled trial evaluating the effects of a transfusion strategy
on morbidity and mortality.
Results: Of the 502 patients enrolled, 52 (10%) had at least 1 major complication. Patients with complications
were older, had a higher EuroSCORE, lower left ventricular ejection fraction, lower preoperative hemoglobin,
a higher prevalence of renal disease, and receivedmore blood transfusions than the group without complications.
Lactate levels were higher in the group with complications at the end of surgery (3.6 mmol/L [2.8-5.1] vs 3.3
mmol/L [2.2-4.8]; P ¼ .018), immediately after intensive care unit (ICU) admission (0 hour) (4.4 mmol/L
[3.1-8.4] vs 4 mmol/L [2.6-6.4]; P ¼ .048); 6 hours (4 mmol/L [2.7-5.8] vs 2.6 mmol/L [2-3.6], P< .001),
and 12 hours after admission (2.3 mmol/L [1.8-3.2] vs 1.7 mmol/L [1.3-2]; P<.001). In a multivariate model,
higher age (odds ratio [OR], 1.048, 95% confidence interval [CI], 1.011-1.086; P ¼ .010), left ventricular
ejection fraction (LVEF) lower than 40% (OR, 3.03; 95% CI, 1.200-7.510; P ¼ .019 compared with LVEF
of 40%-59%; OR, 3.571; 95% CI, 1.503-8.196; P¼ .004 compared with LVEF higher than 60%), higher Euro-
SCORE (OR, 1.138; 95% CI; 1.007-1.285; P ¼ .038), red blood cell transfusion (OR, 1.230; 95% CI,
1.086-1.393; P ¼ .001), and lactate levels 6 hours after ICU admission (OR, 3.28, 95% CI; 1.61-6.69;
P ¼ .001) are predictors of major complications.
Conclusions: Hyperlactatemia 6 hours after ICU admission is an independent risk factor for worse outcomes in
adult patients after cardiac surgery. (J Thorac Cardiovasc Surg 2013;146:455-60)Hyperlactatemia is frequently encountered during and after
cardiac surgery and has many causes that include tissue
hypoxia as well as nonhypoxic causes such as drug therapy,
cardioplegia, hypothermia, and cardiopulmonary bypass
(CPB).1-4 In sepsis and shock states, high levels of blood
lactate have been associated with worse outcomes,
including mortality.5,6
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Mmaintenance of appropriate hemodynamic goals is essential
to improve outcomes after cardiac surgery.1 Perfusion
markers such as central venous oxygen saturation and blood
lactate may, therefore, represent important tools for the
management of these patients.7 The predictive role of hy-
perlactatemia as a prognostic factor in these patients is
not well understood.
The aim of this study was to evaluate whether high lactate
levels after cardiac surgery are predictors of major compli-
cations, including acute respiratory distress syndrome
(ARDS), cardiogenic shock, acute kidney injury needing re-
nal replacement therapy, and mortality.
METHODS
The Transfusion Requirements After Cardiac Surgery (TRACS) study,
which has been previously reported, was designed as a prospective, ran-
domized, noninferiority, controlled trial to look into blood transfusion
thresholds after elective cardiac surgery.8 Consecutive adult patients who
were scheduled for elective cardiac surgery with CPB between February
9, 2009, and February 1, 2010, were enrolled. We excluded patients requir-
ing surgery in an emergency situation, ascending or descending thoracic
aortic procedures, left ventricular aneurysm resection, inability to receive
blood products, pregnancy, cancer, congenital heart defect, hepatic dys-
function, end-stage renal disease, and the refusal to consent. The study
was approved by the Heart Institute Ethics Committee of the Clinicsrdiovascular Surgery c Volume 146, Number 2 455
Abbreviations and Acronyms
ARDS ¼ adult respiratory distress syndrome
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
LVEF ¼ left ventricular ejection fraction
OR ¼ odds ratio
RIFLE ¼ renal risk, injury, failure, loss, end-stage
kidney disease
ROC ¼ receiver operating characteristic
TRACS ¼ Transfusion Requirements After Cardiac
Surgery
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MHospital, University of S~ao Paulo, and written informed consent was ob-
tained from all patients before enrollment. Patients were randomly as-
signed to a liberal (hematocrit values maintained>30%) or restrictive
strategy group (hematocrit values maintained>24%) from the beginning
of the operation until discharge from the intensive care unit (ICU).
In this substudy, we assessed the values of blood lactate measurements
as predictors of postoperative complications in the overall population of
502 patients. Blood lactate levels and blood gases were determined rou-
tinely iRadiometer ABL 835 blood gas analyzer (Radiometer Medical
A/S, Bronshoj, Denmark) during surgery in the operating room, immedi-
ately on the arrival to the ICU (0 hours), and at 6 and 12 hours after ICU
admission.
Outcome Measures
A composite end point for postoperative complications was used and
defined as a combination of 30-day all cause mortality and severe mor-
bidity (cardiogenic shock, ARDS, or acute kidney injury needing renal
replacement therapy during the hospital stay). Cardiogenic shock was
defined as the presence of tachycardia, hypotension, and poor perfusion
associated with a central venous oxygen saturation less than 65%, car-
diac index equal to or lower than 2.2 L $ min1 $ m2, or metabolic ac-
idosis (decrease in base deficit>4) in the absence of a cause other than
heart failure, which occurred after ICU admission.9,10 ARDS was defined
by standard criteria.11 Renal function was evaluated daily using the
RIFLE (renal risk, injury, failure, loss, end-stage kidney disease)
classification.10
Statistical Analysis
Results are expressed as means with standard deviation or medians with
interquartile ranges, as appropriate. Normality was assessed with the
Kolmogorov-Smirnov test. The relationships between the complications
and potential risk factors identified by univariate analysis were assessed
using a c2 test, Fisher’s exact test, likelihood ratio test, t test, or Mann-
Whitney U test. Receiver operating characteristic (ROC) curves were con-
structed, and the area under the ROC curve was determined to assess the
discriminant ability of the lactate concentration measured at intraopera-
tive, at ICU admission (0 hours), 6 hours, and 12 hours after ICU admis-
sion to predict complications. Negative predictive value and positive
predictive value to predict complications were calculated. The ROC curves
also were used to determine the cutoff values of lactate to predict compli-
cations. The cutoff was the value that maximized the sensitivity and
specificity.
A forward multiple logistic regression analysis was then performed to
estimate independent predictive factors for complications. This model in-
cluded risk factors that were first identified by univariate analysis456 The Journal of Thoracic and Cardiovascular Surg(P<.1). And all tests were 2-tailed. Statistical analyses were performed
using SPSS version 18 (SPSS, Inc, Chicago, Ill).RESULTS
A total of 502 patients were enrolled in the original study,
from which 52 (10.4%) patients had at least 1 major com-
plication. Thirty-six (7.2%) patients had 2 or more compli-
cations. Death occurred in 26 (5.2%) patients, cardiogenic
shock in 34 (6.8%), acute kidney injury needing renal re-
placement therapy in 23 (4.6%), and ARDS in 7 (1.4%)
patients.
This group of patients was older (67  11 vs 59  12
years; P<.001) and had a lower prevalence of male gender
(22 [42%] vs 288 [64%]; P¼ .002) than the group without
complications. There was no significant difference in co-
morbidities, except for a higher prevalence of chronic renal
disease (11 [22%] vs 41 [9%]; P ¼ .004) in patients who
had complications (Table 1). The prevalence of patients
with a lower preoperative left ventricular ejection fraction
(LVEF) was higher in the group with complications as com-
pared with the group without complications (LVEF<40%,
16 [31%] vs 53 [12%]; P ¼ .001). Patients with complica-
tions also had a higher operative risk, characterized by
a higher EuroSCORE (7 [5-9] vs 4 [3-6]; P< .001) and
a lower preoperative hemoglobin level (12.6  2.1 vs
13.3  1.7 gm/dL; P ¼ .009) when compared with patients
without complications (Table 1). The group with complica-
tions had a longer duration of hospital stay (14  5 days vs
9  4 days; P<.001) than those who did not.
The patients in whom major complications developed
were more likely to undergo valve surgery (19 [37%] vs
140 [31%]; P<.001) or a combined valve and graft proce-
dure (11 [21%] vs 25 [6%]; P<.001) compared with the
group without complications. They also had a longer dura-
tion of CPB (109  36 minutes vs 93  29 minutes;
P < .001) and a lower hematocrit (27%  5% vs
25%  6%; P ¼ .019), higher final lactate levels at odds
ratio (OR) (3.6 [2.8-5.1] mmol/L vs 3.3 [2.2-4.8] mmol/L;
P ¼ .018), and lower venous oxygen saturation
(74%  11% vs 82%  7%; P< .001) during surgery
than the other patients. They required more blood products
during surgery than did the group without complications
(2 [1-3] vs 1 [0-2]; P< .001), and after ICU admission
(2 [2-4] vs 1 [0-2]; P<.001). There was no significant dif-
ference between groups regarding the strategy of red blood
cell transfusion (Tables 2 and 3).
Patients in whom complications developed had
higher lactate levels immediately after ICU admission
(4.4 [3.1-8.4] vs 4.0 mmol/L [2.6-6.4]; P ¼ .048); 6 hours
(4 [2.7-5.8] vs 2.6 mmol/L [2-3.6]; P<.001); and 12 hours
after admission (2.3 [1.8-3.2] vs 1.7 mmol/L [1.3-2];
P<.001) (Table 2).
Lactate levels of 3 mmol/L after 6 hours of ICU stay and
of 2mmol/L after 12 hours of ICU stay were associated withery c August 2013
TABLE 1. Univariate variable screening findings
Variable Total
Complications
P valueNo (n ¼ 450) Yes (n ¼ 52)
Age (y), mean (SD) 60  12 59  12 67  11 <.001
Men 310 (62%) 288 (64%) 22 (42%) .002
Body mass index (kg/m2), mean (SD) 26  4 26  4 26  5 .967
Comorbid conditions
Hypertension 393 (78%) 350 (78%) 43 (83%) .416
Diabetes 165 (33%) 144 (32%) 21 (40%) .236
Dyslipidemia 286 (57%) 253 (56%) 33 (65%) .260
Renal disease 52 (11%) 41 (9%) 11 (22%) .004
COPD 14 (3%) 13 (3%) 1 (2%) 1.000
Unstable angina 155 (31%) 140 (31%) 15 (29%) .738
Previous myocardial infarction 175 (35%) 158 (35%) 17 (33%) .784
Heart failure, NYHA classification
I 17 (6%) 11 (5%) 5 (14%) .313
II 110 (39%) 76 (37%) 14 (39%)
III 94 (33%) 99 (48%) 15 (42%)
IV 61 (22%) 19 (9%) 2 (6%)
LVEF (%)
<40 69 (14%) 53 (12%) 16 (31%) .001
40-59 151 (30%) 137 (30%) 14 (27%)
60 282 (56%) 260 (58%) 22 (42%)
Reoperation 68 (14%) 60 (13%) 8 (15%) .682
EuroSCORE, median (IQR) 4 (3-6) 4 (3-6) 7 (5-9) <.001
Preoperative laboratory values, mean (SD)
Hemoglobin (g/dL) 12.6  1.7 13.3  1.7 12.6  2.1 .009
Hematocrit (%) 39  5 40  5 39  6 .071
Prothrombin time (s) 11.1  1.6 11.1  1.6 11.4  1.4 .248
Platelet count (3103/mL) 223  66 224  66 218  67 .526
Creatinine level (mg/dL) 1.12  0.35 1.11  0.35 1.21  0.37 .081
Leukocyte count (/mL) 7635  2065 7640  2084 7596  1918 .889
Preoperative drug exposure
Aspirin 197 (39%) 176 (39%) 21 (40%) .868
Heparin 5 (1%) 5 (1%) 0 (0%) 1.000
SD, Standard deviation; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; EuroSCORE, European
System for Cardiac Operative Risk Evaluation; IQR, interquartile range.
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Mmajor postoperative complications, resulting in an area un-
der the ROC curve of 0.72 (95% confidence interval [CI],
0.64-0.79; P < .001) and 0.75 (95% CI, 0.66-0.83;
P<.001), respectively (Figure 1).
In a multivariate model, higher age (OR, 1.048; 95% CI,
1.011-1.086; P ¼ .010), LVEF lower than 40% (OR, 3.03;
95% CI, 1.200-7.510; P ¼ .019; compared with LVEF of
40%-59%, OR, 3.571; 95% CI, 1.503-8.196; P ¼ .004;
compared with LVEF higher than 60%), higher Euro-
SCORE (OR, 1.138; 95% CI, 1.007-1.285; P ¼ .038), red
blood cell transfusion (OR, 1.230; 95% CI, 1.086-1.393;
P ¼ .001), and lactate levels 6 hours after ICU admission
(OR, 3.28; 95% CI, 1.61-6.69; P ¼ .001) are predictors
of major complications (Table 4).
DISCUSSION
This study has demonstrated that lactate levels at the end
of cardiac surgery, immediately after ICU admission andThe Journal of Thoracic and Caalso at 6 and 12 hours later, are related to postoperative ad-
verse events. A threshold of 3 mmol/L at 6 hours after ad-
mission to the ICU and of 2 mmol/L at 12 hours identifies
patients with worse outcomes including a higher rate of
30-day mortality after cardiac surgery. Also, a lactate level
exceeding 3 mmol/L at 6 hours after surgery is indepen-
dently associated with a 3.3 times risk of a major compli-
cation after cardiac surgery, including death. Although the
causes of these high lactate levels are numerous and
diverse, these results raise the possibility that targeting
therapy to reduce or prevent the initial increase in this vari-
able may prevent complications and improve postoperative
outcomes.
Cardiac surgery may result in an imbalance between ox-
ygen demand and supply, leading to tissue hypoxia and ulti-
mately to organ failure.12,13 Factors such as inadequate
myocardial protection, residual ischemia, and longer
duration of CPB are widely known risk factors for tissuerdiovascular Surgery c Volume 146, Number 2 457
TABLE 2. Intraoperative data, laboratory findings, and cardiac
procedure details
Variable
Complications
P valueNo (n ¼ 450) Yes (n ¼ 52)
Procedure
CABG surgery 285 (63%) 22 (42%) <.001
Valve surgery 140 (31%) 19 (37%)
CABG þ valve surgery 25 (6%) 11 (21%)
No. of grafts per patient
1 28 (9%) 4 (12%) .395
2 93 (30%) 6 (18%)
3 129 (42%) 15 (45%)
4 50 (16%) 8 (24%)
>4 10 (3%) 0 (0%)
ITA graft 281 (91%) 28 (85%) .351
CPB (min) 93  29 109  36 <.001
Crossclamp time (min) 42 (41-44) 43 (42-44) .099
Hemoglobin (g/dL)
Initial 12.6  1.7 12.4  1.8 .408
Middle 8.8  2.3 8.5  3.2 .367
Final 10.4  1.4 10.2  1.4 .374
Hematocrit (%)
Initial 39  5 38  5 .373
Middle 27  5 25  6 .019
Final 32  4 31  4 .239
Lactate (mmol/L)
Initial 1.6 (1.2-1.9) 1.4 (1.1-1.9) .442
Final 3.3 (2.2-4.8) 3.6 (2.8-5.1) .018
ScVO2 (%)
Initial 74  9 71  10 .045
Final 82  7 74  11 <.001
Fluid administered (mL) 3000 (2500-3500) 3000 (2500-3500) .429
Crystalloids (mL) 2500 (2000-3000) 2500 (2500-3000) .832
Albumin 3 (1%) 1 (2%) .355
Hydroxyethylstarch
6% (130/0.4)
189 (42%) 28 (54%) .103
Transfused RBCs, units
(median, IQR)
1 (0-2) 2 (2-4) <.001
Platelet transfusion 27 (6%) 6 (12%) .137
Fresh frozen plasma 76 (17%) 21 (40%) <.001
Cryoprecipitate 9 (2%) 2 (4%) .318
Liberal strategy of RBC
transfusion
229 (50.9%) 24 (46.2%) .850
CABG, Coronary artery bypass grafting; ITA, internal thoracic artery; CPB, cardio-
pulmonary bypass; ScVo2, Central venous oxygen saturation; RBC, red blood cells;
IQR, interquartile range.
TABLE 3. RBC unit exposure and lactate levels after ICU admission
Variable
Complications
P valueNo (n ¼ 450) Yes (n ¼ 52)
Transfused RBC units
(median, IQR)
1 (0-2) 2 (2-4) <.001*
Lactate (mmol/L) after ICU
admission (median, IQR)
0 4 (2.6-6.4) 4.4 (3.1-8.4) .048*
6 h 2.6 (2-3.6) 4 (2.7-5.8) <.001*
12 h 1.7 (1.3-2) 2.3 (1.8-3.2) <.001*
RBC, Red blood cell; ICU, intensive care unit; IQR, interquartile range. *Mann-Whit-
ney test.
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Mhypoperfusion and consequently for worse outcomes after
cardiac surgery.1,2 Despite many advances in the care of
these patients and low rates of mortality for elective
cardiac procedures, complications remain frequent.
Crucial to implementing adequate treatment is the
definition of appropriate goals for treatment and predictive
factors for complications. In sepsis, lactate levels have
been used as a resuscitation end point and as predictors of
both short- and long-term complications and mortality.5 In
cardiac surgery, however, the role of hyperlactatemia as458 The Journal of Thoracic and Cardiovascular Surga marker of tissue hypoperfusion and worse outcomes is
a matter of controversy.
Our results are consistentwith reports in surgical and non-
surgical settings where elevated lactate concentrations and
prolonged lactate clearance were associated with morbidity
and death.14,15 Polonen and associates16 showed that nor-
malizing lactate concentrations as a therapeutic goal is asso-
ciated with decreased morbidity and hospital length of stay
in patients undergoing cardiac surgery. Although some stud-
ies have described lactate levels higher than 3 mmol/L as
being associated with worse outcomes in critically ill surgi-
cal patients,6,17 other investigations have discussed which is
the appropriate range for lactate values in these patients.18,19
This study has shown that lactate concentrations higher
than 3 mmol/L 6 hours after ICU admission are indepen-
dently associated with major complications after cardiac
surgery, including death. Our data are different from the
findings of Maillet and colleagues,1 who reported that
higher lactate levels at ICU admission were associated
with complications that included a longer duration of me-
chanical ventilation and length of ICU stay. We hypothe-
sized that during surgery and immediately after ICU
admission, hyperlactatemia may be due to other causes
than tissue hypoperfusion, such as cardioplegia, hypother-
mia, and CPB.
This study brings a new perspective to the role of lactate
monitoring after cardiac surgery. Previous studies have fo-
cused their attention on the moment that hyperlactatemia
arises, dividing between immediate and delayed hyperlacta-
temia. According to these studies, patients in whom hyper-
lactatemia develops during their ICU stay have the same
outcome as patients who have normal lactate levels during
the same period. In addition, patients who have hyperlacta-
temia immediately after ICU admission have worse out-
comes than do the other patients.1,2
The origin of the hyperlactatemia after cardiac surgery is
multifactorial. Hyperlactatemia can occur even in the ab-
sence of tissue hypoperfusion.20 It can involve a reduced
liver clearance of lactate secondary to the effect of the anes-
thetics and the low temperatures during CPB on the cellular
metabolism.20,21 In addition, the use of catecholaminesery c August 2013
FIGURE 1. Receiver operating characteristic (ROC) curve comparing the ability of immediate postoperative, 0-hour, 6-hour, and 12-hour lactate levels
after intensive care unit (ICU) admission in predicting major complications after cardiac surgery. OR, Operating room; AUC, area under the curve; CI, con-
fidence interval; PPV, positive predictive value; NPV, negative predictive value.
Hajjar et al Perioperative Managementduring cardiac surgery can lead to increased lactate levels
owing to their action on oxidative glucose metabolism.22,23
Patients undergoing uncomplicated cardiac surgery can
often have a transient hyperlactatemia. In our study, the pa-
tients who still had lactate levels higher than 3mmoL/L after
6 hours and higher 2 mmol/L after 12 hours of ICU stayTABLE 4. Multiple logistic regression to determine predictive factors
for major complication after cardiac surgery
Variable
Estimated
parameter SE OR 95% CI P value
Age (y) 0.044 0.017 1.048 1.011 1.086 .010
LVEF .010
<40 (%)
40-59 (%) 0.899 0.451 3.030 1.20 7.51 .019
>60 (%) 1.176 0.426 3.571 1.503 8.196 .004
EuroSCORE 0.137 0.060 1.138 1.007 1.285 .038
Transfuse red
blood cell units
0.195 0.062 1.230 1.086 1.393 .001
Lactate 6 h
<3 mmol/L Reference
>3 mmol/L 1.236 0.351 3.280 1.607 6.694 .001
Model sensitivity and specificity¼ 74%. SE, Standard error;OR, odds ratio; CI, con-
fidence interval; LVEF, left ventricular ejection fraction; EuroSCORE, European Sys-
tem for Cardiac Operative Risk Evaluation.
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Mcould represent a subgroup of patients with hyperlactatemia
secondary to occult tissue hypoperfusion. These findings
suggest that a strategy of hemodynamic optimization using
other parameters such as cardiac index, calculated oxygen
delivery, and central venous oxygen saturation in patients
with early hyperlactatemia aiming a serum lactate under 3
mmol/L in the first 6 hours and under 2 mmol/L in the first
12 hours of ICU admission may reduce the incidence of ma-
jor complications, as reported by previous studies.4,16,24,25
Other classic risk factors for worse outcomes after car-
diac surgery, including increased age, lower LVEF, higher
EuroSCORE, and red blood cell transfusion, were also pre-
dictors of major complications in our patients. These data
are similar to other previous studies.25-28 The additional
role of lactate as a risk factor suggests that in the clinical
setting, it might help physicians in the perioperative
planning to drive patients’ monitoring and therapy.
Our study has the limitation of being performed in a sin-
gle center, with a relatively small number of patients, which
could restrict the generalization of our findings. In addition,
we have used data from a previous prospective study that
was not specifically designed for this purpose. Despite
this, our data set is large and well validated, enabling us
to be confident of our estimates and assumptions.rdiovascular Surgery c Volume 146, Number 2 459
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P
MIn conclusion, lactate level 6 hours after ICU admission is
an independent predictor of postoperative complications in-
cluding 30-day all-cause mortality and severe morbidity af-
ter cardiac surgery in adult patients. Randomized,
controlled trials are needed to evaluate the potential benefit
of a strategy aiming at normalizing lactate levels after car-
diac surgery.
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